ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Gross margin 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) gross margin by fiscal year — reported gross profit divided by reported revenue.
74.2%FY2025 · since FY2017: 59.2% → 74.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 74.2% | +14.5 pp |
| FY2024 | 59.7% | +4.1 pp |
| FY2023 | 55.6% | -13.1 pp |
| FY2022 | 68.7% | +0.7 pp |
| FY2021 | 68.1% | -9.0 pp |
| FY2020 | 77.1% | +3.3 pp |
| FY2019 | 73.8% | +9.2 pp |
| FY2018 | 64.7% | +5.4 pp |
| FY2017 | 59.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ADPT financial trends
ADPT RevenueADPT Net incomeADPT Net marginADPT Gross profitADPT Operating incomeADPT Operating marginADPT Operating cash flowADPT Free cash flowADPT Capital expendituresADPT Return on equityADPT Stock buybacksADPT Dividends paidADPT Total assetsADPT Total liabilitiesADPT Shareholders’ equityADPT overview →